Authors/Disclosures
|
Deniz Erten-Lyons, MD, FAAN
(FDA)
|
Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals. |
|
Randall L. Woltjer
(Oregon Health & Science University)
|
Randall L. Woltjer has nothing to disclose. |
|
Hiroko H. Dodge, PhD
(Massachusetts General Hospital)
|
No disclosure on file |
|
Lisa Silbert, MD, FAAN
(OHSU)
|
The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH. |
|
Kristina M. Fanning, PhD
(MIST Reserach)
|
The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA. |
|
Patricia L. Kramer, PhD
(Oregon Health Sciences University)
|
No disclosure on file |
|
Jeffrey A. Kaye, MD, FAAN
(Oregon Hlth Sci Univ.)
|
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |